BridgeMD
New treatment option for Cancer
Official title Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients
ClinicalTrials.gov ID: NCT07182773
What this study is testing
- What it's testing
- Background to this Research Patients who undergo cancer treatment involving chemotherapy or immunotherapy, can experience considerable reductions in their fitness levels. This is a concern, as exercise is a really important part of cancer care.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged \>18.
- Histological confirmed diagnosis of stage I to IIIc breast, ovarian, or colorectal cancer.
- Scheduled to receive chemotherapy ± immunotherapy with curative intent over at least a 12-week period.
- Medical clearance from oncologist to partake in regular exercise in accordance with ACSM preparticipation screening algorithm.
- Able to use exercise bike independently.
You likely can't join if
- Advanced/metastatic disease.
- Scheduled to receive concurrent chemoradiotherapy.
- New pain or other pain that would preclude ability to use bike.
- Inability to read and understand English.
- Deemed unfit to proceed from results of CPET.
- Unstable angina, arrhythmia, hypertension or decompensated heart failure.
See the full eligibility criteria
- Aged \>18.
- Histological confirmed diagnosis of stage I to IIIc breast, ovarian, or colorectal cancer.
- Scheduled to receive chemotherapy ± immunotherapy with curative intent over at least a 12-week period.
- Medical clearance from oncologist to partake in regular exercise in accordance with ACSM preparticipation screening algorithm.
- Able to use exercise bike independently.
- Ability to provide written informed consent.
- Advanced/metastatic disease.
- Scheduled to receive concurrent chemoradiotherapy.
- New pain or other pain that would preclude ability to use bike.
- Inability to read and understand English.
- Deemed unfit to proceed from results of CPET.
- Unstable angina, arrhythmia, hypertension or decompensated heart failure.
- Dementia or psychiatric illness which would preclude safe independent exercise.
- Acute untreated embolus/infarct.
- Dissecting aneurysm.
- Acute myocarditis or pericarditis.
The study team makes the final eligibility decision.
Where it's taking place
- Dublin, Ireland
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dublin, Ireland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.